U.S. Trade Distributors Stock News

Sphere Entertainment Co. recently announced that The Wizard of Oz at Sphere will add new 4D effects including animatronic Winged Monkeys, themed scents, “Glinda Glitter,” pyrotechnic fireworks, and scented apples, building on the immersive show that has run with multiple daily performances since August 2025. The expanded sensory features, developed with Warner Bros. Discovery, Google and Magnopus, signal ongoing content investment aimed at deepening guest engagement and reinforcing Sphere...

High dividend stocks are back under the spotlight as 10-year Treasury yields hover near 4.85% and bond investors push up the hurdle rate for every future cash flow you might own. Cash-generative value stocks suddenly feel a lot more interesting when bond markets are questioning long term debt sustainability. This article unpacks 3 high dividend, defensive stocks from our screener that appear especially exposed to this rate driven story, potentially in a way that could be favorable for...

Incyte reported that MINJUVI, a CD19-targeted monoclonal antibody for relapsed or refractory follicular lymphoma, is now funded in Ontario via the FAST Program, giving eligible patients earlier access while reimbursement reviews continue. This provincial funding decision signals real world traction for MINJUVI in a key Canadian market and may influence how investors view Incyte's efforts to broaden its oncology portfolio beyond Jakafi. We will now look at how Ontario funding support for...

Higher-for-longer interest rates combined with easing lending standards have turned attention to Enova International (ENVA), as the consumer lender expands through acquisitions and leans on advanced analytics and AI across its platform. Enova International’s recent pullback, with the share price down 13.25% over the past 30 days and 4.34% over the last week, comes after a strong run that includes a 17.82% 90 day share price return and a 1 year total shareholder return of 89.87%. This suggests...

Regency Centers (REG) is back in focus after EVgo and the retail REIT agreed to expand their fast charging partnership, with plans to add more than 400 stalls across U.S. shopping centers. For context, Regency Centers shares trade at US$75.31, with short term share price returns over the past quarter drifting lower. However, the year to date share price return of 10.82% and a 3 year total shareholder return of 32.45% point to more durable momentum. Scan for other retail REITs that pair...

Verisk Analytics recently launched Verisk Fraud Discovery, a modular anti fraud platform, and a U.S. Data Center Exposure Database aimed at helping insurers, reinsurers and brokers assess fraud and data center risk with more granular analytics and case management tools. The pairing of unified fraud detection with detailed data center exposure mapping shows Verisk Analytics leaning further into high value, workflow embedded risk intelligence that speaks directly to insurers' fraud,...

Valley National Bancorp (VLY) has put technology in the spotlight, unveiling its new Valley Foundry unit focused on AI, cybersecurity and efficiency, shortly after reporting better than expected quarterly revenue. Recent trading tells a mixed story. The 1-day share price return of 0.65% comes after the stock fell 4.1% following the earnings release, while the 30-day share price return is down 7.23% and year to date the share price return is up 18.48%. Over a longer horizon, total shareholder...

Braze reported second quarter 2026 revenue of US$227.23 million and a net loss of US$18.85 million, issued third quarter revenue guidance of US$229 million to US$230 million, and updated full year 2026 to 2027 revenue guidance to US$910 million to US$913 million, while completing a US$50 million buyback program. The business highlighted strong BrazeAI adoption and a new three year agreement with AWS. Investors focused on third quarter earnings guidance that fell short of expectations,...

Tango Therapeutics reported a wider than expected loss in the second quarter of 2026 as operating expenses weighed on results and collaboration revenue dropped to zero after ending research activities tied to its Gilead partnership. The absence of collaboration income puts more focus on Tango Therapeutics’ own pipeline progress and cash usage, since higher internal spending now drives reported losses without the prior offset from external funding. This raises questions about how Tango...

Rogers reported year on year revenue growth that exceeded analyst expectations, raised next quarter revenue guidance above forecasts, but delivered an earnings per share miss and the weakest Q2 performance among its peers. The company also held an Investor Day in September 2026, where leadership outlined multi-year financial objectives and capital allocation plans, giving investors more visibility into how management intends to convert stronger top-line momentum into improved...

AEVEX (AVEX) has just reported US$20.5 million in new awards tied to one way attack systems for U.S. government customers, drawing fresh attention to how this defense contractor prices risk and opportunity. Despite the new contracts and recent expansion moves in Florida and Virginia, AEVEX’s short term trading has been weak, with the 30 day share price return down 28.2% and the year to date share price return down 40.9% at a latest share price of US$15.91. Scan beyond AEVEX and spot other...

Marvell Technology (MRVL) has just finished a long running share repurchase effort, buying back 104,557,088 shares for about US$4.6b since a program launched in 2016. Marvell Technology’s 1-year total shareholder return of 237.7% and 3-year total shareholder return of about 3.2x sit against a recent 90-day share price pullback of 18.9%, with the current US$226.96 level reflecting both strong AI-related news flow and shifting risk appetite. Scan beyond Marvell Technology's buyback story and AI...

McCormick has had a difficult stretch over the past few years, with the share price retreating while the valuation checks now lean more favourable than the current mood around the stock might suggest. Over the past 5 years, McCormick shares have declined 33.5%, which means long term holders have carried a meaningful drawdown that colours how new buyers may look at today’s price. Future valuation for McCormick may hinge on how consistently the business converts its seasoning and flavor...

Analog Devices (NasdaqGS:ADI) has signed a definitive agreement to acquire Alif Semiconductor to expand its AI-native edge computing portfolio. The deal brings Alif’s AI-focused microcontrollers and fusion processors into ADI’s platform for real-time sensor fusion and on-device AI. Management expects the acquisition to support applications across industrial, defense, robotics, digital health, and wearable devices. Consider broadening your watchlist to other companies building AI...

Par Pacific Holdings has recently drawn attention after Zacks assigned it a Rank #1, supported by a 36.7% uplift in full-year earnings estimates and a 133.6% year-to-date return compared with the broader Oils-Energy sector. The key story is not the ranking itself but what sits behind it, with analysts marking up earnings expectations as Par Pacific outperforms other refiners in its Oil and Gas, Refining and Marketing peer group. Next, the focus turns to how this sharp reset in earnings...

FIGS (FIGS) is heading to Barclays’ 19th Annual Global Consumer Staples Conference in Boston on 8 September 2026, where CEO Trina Spear and CFO Sarah Oughtred are scheduled to outline the healthcare apparel specialist’s current priorities. FIGS heads into the Barclays conference after a choppy few weeks, with the share price down 14.8% over the last 7 days and 9.25% over 30 days, yet still sitting on a 13.7% year to date share price gain and a 77.4% 1 year total shareholder return that...

Amdocs stock has had a difficult run, with the share price drifting lower over the past year even as broader valuation checks suggest it might be on the cheap side. For investors, the puzzle is whether that weak share performance is flagging deeper business concerns or simply masking an opportunity in a lowly valued telecom software provider. Over the past 12 months, Amdocs shares have fallen 27%, which points to a market that has grown more cautious on the business. The company’s ability to...

Griffon has delivered a very large 5 year share price gain, yet current valuation checks suggest the stock still trades at a discount to its estimated intrinsic value. Recent setbacks over the past month sit alongside an intrinsic value estimate that comes in higher than the latest closing price, which raises questions about how conservative the market is being on this business. The share price has climbed 387.8% over 5 years, which puts Griffon in a very strong long run performance bracket...

Motorola Solutions reported that its board approved a US$2b increase to the share repurchase authorization, taking the long running program to US$20b with no set expiry, with repurchases possible in the open market or through privately negotiated transactions. The larger buyback pool highlights management’s focus on capital return and indicates that free cash flow generation supports ongoing share repurchases alongside core public safety and enterprise security investments. With Motorola...

AXIS Capital Holdings stock has delivered a strong 142.1% gain over the past five years, yet its valuation checks still suggest the shares lean on the cheap side rather than fully reflecting that performance. The 142.1% total return over five years points to a business that has rewarded patient holders. This puts extra focus on whether that run already prices in the insurer’s strengths. Recent affirmation of strong credit ratings can support confidence in AXIS Capital Holdings’ balance...

Atlassian announced new Jira and DX capabilities in September 2026 that connect Code Context, governed agent workflows, and DX for Agentic Development to manage AI driven software development across planning, coding, review, and measurement. The updates focus on governed agent loops, code standards, and usage analytics, which tie AI activity directly to engineering throughput, quality, and cost tracking for enterprise customers. With Atlassian advancing governed agentic workflows such as...

Inflation pressures are creeping back into the headlines, Fed hike odds are edging higher, and suddenly the steady cash flows of US large-cap value and high-dividend stocks look far more interesting than last year’s growth darlings. Investors are hunting for companies that can shoulder higher costs, keep paying shareholders, or even benefit from a higher-for-longer rate path. This article walks through three such stocks exposed to these forces and explains why they may merit a closer look...

RTX (NYSE:RTX) unit RTX Ventures agreed to take a minority stake in Xcimer Energy and form a new alliance around pulsed-laser technology. The partnership targets integration of scalable multi-kilojoule-class pulsed-laser systems into RTX defense platforms to counter emerging airborne threats. The move follows the U.S. Department of Energy approval of Xcimer’s fusion pilot plant, adding weight to the underlying laser and fusion technology. The agreement could broaden RTX’s exposure to both...

Inflation’s next big test arrives with the August CPI report, and the outcome could reshape how investors think about U.S. oil and gas refiners just days before the Fed’s September 16 meeting. Higher rates and stubborn energy costs can quickly change which stocks benefit and which struggle. This article walks through three U.S. refiners exposed to this news and explains how each might fit, or not, in your playbook. The refiners covered below are only a small sample of what meets the CPI and...